Portfolio company
Sencilia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
Volusense
The company develops non-invasive, mask-free respiratory monitoring systems used by neonatologists and paediatricians to evaluate lung function in preterm and term infants.
Cimon Medical
This company develops Doppler ultrasound technology for continuous blood flow monitoring in premature and critically ill infants within healthcare facilities.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
Innocens
Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.
Medyria AG
The company develops sensor-equipped microcatheters that measure blood flow velocity for interventional cardiologists to diagnose ischemic heart conditions.
TheraB Medical
The company develops wearable phototherapy devices for newborns with jaundice to allow continued bonding and breastfeeding during treatment.
